University of Sydney researchers are developing a surface coating that could stop blood clotting in medical devices like catheters and stents.

An FDA-approved osteoporosis treatment might nudge a mutated protein back into shape and improve heart function, according to a study by University of Arizona College of Medicine – Tucson researchers.

HMRI has partnered with Novartis Australia to revolutionize cardiovascular health. Through a newly signed Memorandum of Understanding (MoU), we are combining our expertise with world-class research and cutting-edge medical solutions to fast-track innovations that will save lives. From lipid management to new models of care, this collaboration is about real impact; helping patients access the treatments they need, when they need them. Together, we are working toward a future where cardiovascular disease is no longer the leading cause of death in Australia.

Adults with a history of depression gain long-term physical conditions around 30% faster than those without, according to research publishing February 13^th in the open-access journal PLOS Medicine. Kelly Fleetwood of the University of Edinburgh, United Kingdom, and colleagues argue that their study suggests depression should be viewed as a ‘whole body’ condition, and integrated approaches should be used to manage mental and physical health.